Amit K. Verma, M.B.,B.S.

Medicine

Phone718-430-8761
Emailamit.verma@einstein.yu.edu
Websitehttp://www.einstein.yu.edu/faculty/10065/amit-verma/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

45 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Active
5 Finished

Therapeutic targeting of MDS stem cells
Steidl, U. G. & Verma, A. K.
National Heart, Lung, and Blood Institute
8/20/18 → 6/30/21
Project: Research project
Therapeutic targeting of glutamine metabolism in MDS
Verma, A. K. & Verma, A. K.
4/1/16 → 3/31/21
Project: Research project
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Verma, A. K.
1/1/19 → 6/30/20
Project: Research project
Early Detection of Hematologic Malignancies in New York City Firefighters Exposed To World Trade Center Dust After The 9/11 Attacks
Prezant, D. J., Verma, A. K. & Prezant, D. J.
National Institutes of Health
7/1/17 → 6/30/20
Project: Research project
Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes
Verma, A. K. & Verma, A. K.
National Institute of Diabetes and Digestive and Kidney Diseases
9/1/14 → 5/31/18
Project: Research project

8201 Citations
54 h-Index
166 Article
28 Review article
13 Letter
8 Comment/debate
3 More
- 3 Chapter

A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19
Gonzalez-Lugo, J. D., Bachier-Rodriguez, L., Goldfinger, M., Shastri, A., Sica, R. A., Gritsman, K., Mehta, V., Kabarriti, R., Goel, S., Verma, A., Braunschweig, I., Kornblum, N. & Mantzaris, I., Aug 1 2020, In : British Journal of Haematology. 190, 3, p. e130-e133
Research output: Contribution to journal › Letter › peer-review

Open Access

2 Scopus citations
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
Abbasi, A., Peeke, S., Shah, N., Mustafa, J., Khatun, F., Lombardo, A., Abreu, M., Elkind, R., Fehn, K., De Castro, A., Wang, Y., Derman, O., Nelson, R., Uehlinger, J., Gritsman, K., Sica, R. A., Kornblum, N., Mantzaris, I., Shastri, A., Janakiram, M. & 4 others, Goldfinger, M., Verma, A., Braunschweig, I. & Bachier-Rodriguez, L., Jan 3 2020, In : Journal of Hematology and Oncology. 13, 1, 1.
Research output: Contribution to journal › Article › peer-review

Open Access
8 Scopus citations
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes
Verma, A., Suragani, R. N. V. S., Aluri, S., Shah, N., Bhagat, T. D., Alexander, M. J., Komrokji, R. & Kumar, R., Feb 3 2020, In : Journal of Clinical Investigation. 130, 2, p. 582-589 8 p.
Research output: Contribution to journal › Review article › peer-review
4 Scopus citations
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., Pradhan, K., Thota, R., Reissman, S., Sparano, J. A., Gartrell, B. A., Smith, R. V., Ohri, N., Garg, M., Racine, A. D., Kalnicki, S., Perez-Soler, R., Halmos, B. & Verma, A., Jul 1 2020, In : Cancer discovery. 10, 7, p. 935-941 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
120 Scopus citations
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
COVID-19 and Cancer Consortium, Jun 20 2020, In : The Lancet. 395, 10241, p. 1907-1918 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
147 Scopus citations